Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

Clinical trial NCT03595813 · COMPLETED

Trial details

NCT number: NCT03595813
Sponsor: Institut Paoli-Calmettes
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Cancer Metastatic Locally Advanced Malignant Neoplasm Non Hodgkin Lymphoma Urologic Neoplasms

Start date: 2018-01-29
Primary completion: 2020-07-17
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.